Events Calendar

Upcoming Events

Date Title
November 29, 2017 at 2:45 PM EST
Spark Therapeutics, Inc. at Evercore ISI Biopharma Conference
November 30, 2017 at 10:20 AM EST
Spark Therapeutics, Inc. at Barclays Gene Editing/Therapy Summit
November 30, 2017 at 2:45 PM EST
Spark Therapeutics, Inc. at Forbes Healthcare Summit on “Gene Therapy Comes of Age”
Description:
Forbes Healthcare Summit on “Gene Therapy Comes of Age” on Thursday, Nov. 30, at 2:45 PM ET at the Jazz at Lincoln Center in New York
December 14, 2017 at 10:30 AM EST
Spark Therapeutics, Inc. at 2017 Prescriptions for Success Healthcare Conference

Past Events

Date Title
November 16, 2017 at 2:00 PM GMT
Spark Therapeutics, Inc. at Jefferies 2017 London Healthcare Conference
November 15, 2017 at 1:00 PM EST
Spark Therapeutics, Inc. at Personalized Medicine Coalition’s 13th Annual Personalized Medicine Conference
Description:
Personalized Medicine Coalition’s 13th Annual Personalized Medicine Conference on “The Designer Genome: Exploring the Implications of Gene Editing and Gene Therapy for the Future of Medicine and Humanity” on Wednesday, Nov. 15, at 1:00 PM ET at the Joseph B. Martin Conference Center at Harvard Medical School in Boston
November 14, 2017 at 2:00 PM EST
Spark Therapeutics, Inc. at Stifel Healthcare Conference
November 10 - November 14, 2017
Spark Therapeutics, Inc. at American Academy of Ophthalmology (AAO), at the Ernest N. Morial Convention Center in New Orleans
Description:

Albert M. Maguire, M.D., a principal investigator for the Phase 3 clinical trial of LUXTURNATM (voretigene neparvovec), professor of ophthalmology at the Scheie Eye Institute at the University of Pennsylvania’s Perelman School of Medicine and attending physician in the Division of Pediatric Ophthalmology at Children's Hospital of Philadelphia, will present at AAO Retina Subspecialty Day on “Three-Year Update for Phase 3 Voretigene Neparvovec Study in Biallelic RPE65-Mediated Inherited Retinal Disease” on Friday, Nov. 10, at 4:01PM CT.

Stephen R. Russell, M.D., a principal investigator for the Phase 3 clinical trial of LUXTURNA, Schrage Professor of Ophthalmology at the Stephen A. Wynn Institute for Vision Research at the University of Iowa, will present at AAO 2017 on “Phase 3 Trial Update of Voretigene Neparvovec in Biallelic RPE65-Mediated Inherited Retinal Disease” on Tuesday, Nov. 14, at 10:15 AM CT.

November 9 - November 10, 2017
Spark Therapeutics, Inc. at World Federation of Hemophilia (WFH) Global Forum, at the Marriott Château Champlain in Montreal
Description:

John Furey, chief operating officer, will participate in a panel discussion on “How Will We Afford New Treatments?” on Thursday, Nov. 9. For the time of the panel discussion, please click here.

Marcus E. Carr, M.D., head of clinical development, will present previously disclosed data in an “Overview of Spark Adeno-Associated Virus Mediated Gene Transfer Platforms for Investigational Hemophilia A and B Programs” on Friday, Nov. 10, at 8:30 AM ET

November 8, 2017 at 10:25 AM MST
Spark Therapeutics, Inc. at Credit Suisse Healthcare Conference
November 7, 2017 at 8:30 AM EST
Q3 2017 Spark Therapeutics, Inc. Earnings Conference Call
September 27, 2017 10:30 AM EDT
Spark Therapeutics, Inc. at Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology
Location:
Lotte New York Palace

New York,
United States

September 26, 2017 3:25 PM EDT
Spark Therapeutics, Inc. at Cantor Fitzgerald Global Healthcare Conference
Location:
InterContinental New York Barclay Hotel

New York,
United States

September 13, 2017 10:30 AM EDT
Spark Therapeutics, Inc. at Morgan Stanley Global Healthcare Conference
Location:
Grand Hyatt

New York,
United States

September 7, 2017 11:00 AM EDT
Spark Therapeutics, Inc. at Citi 12th Annual Biotech Conference
Location:
Mandarin Oriental

Boston,
United States

September 6, 2017 3:35 PM EDT
Spark Therapeutics, Inc. at Wells Fargo Securities Healthcare Conference
Location:
Westin Boston Waterfront

Boston,
United States

August 2, 2017 8:30 AM EDT
Q2 2017 Spark Therapeutics, Inc. Earnings Conference Call
July 10, 2017 at 12:00 PM EDT to July 11, 2017 at 11:59 PM EDT
Spark Therapeutics, Inc. at the International Society on Thrombosis and Haemostasis (ISTH) 2017 Congress
Description:
  • “SPK-9001: Adeno-associated Virus Mediated Gene Transfer for Haemophilia B Achieved Durable Endogenous Prophylaxis at Levels of Activity Sufficient to Achieve Significant Mean Reduction in Annual Bleeding and Infusions Rates in Preliminary Data from an Ongoing Phase 1/2a Trial,” Lindsey George, M.D., on Monday, July 10, from 5:45 to 6 p.m. CET
  • “Gene Therapy Replacement,” Katherine A. High, M.D., on Tuesday, July 11, from 8 to 8:25 a.m. CET
  • “Preliminary Results of SPK-9001 Gene Transfer Demonstrate Statistical Improvements on the Health-related Quality-of-Life in Adults with Haemophilia B Speaker,” Sylvia von Mackensen, Ph.D., poster session on Tuesday, July 11, from 12 to 1:15 p.m. CET
June 22, 2017 12:00 PM EDT
Spark Therapeutics, Inc. at J.P. Morgan European Healthcare Conference
Location:

London,
United States

June 14, 2017 4:00 PM PDT
Spark Therapeutics, Inc. at Goldman Sachs 38th Annual Global Healthcare Conference
Location:
Terranea Resort

Rancho Palos Verdes, CA
United States

June 6, 2017 4:00 PM EDT
Spark Therapeutics, Inc. at Jefferies 2017 Healthcare Conference
Location:
Grand Hyatt

NY
United States

May 9, 2017 at 12:00 PM EDT to May 13, 2017 at 11:59 PM EDT
Spark Therapeutics, Inc. at American Society of Gene & Cell Therapy 2017 Annual Meeting
Description:
  • Katherine A. High, M.D., president and chief scientific officer, will present on “Clinical-Development Pathways in Gene-based Therapeutics,” as part of the Clinical Pathways from Lab to (Almost) Licensure session on Tuesday, May 9, from 2:20 to 4 p.m. EDT
  • Xavier M. Anguela, Ph.D., head of discovery, will present “SPK-9001: Adeno-Associated Virus Mediated Gene Transfer for Hemophilia B at the Low Vector Dose Achieved Sustained, Continuous Factor IX Activity Levels Adequate for Endogenous Prophylaxis Preventing Bleeding Episodes and Reducing the Risk of Immune Response,” during the Clinical Trials Spotlight Symposium on Saturday, May 13, from 8:15 to 8:35 a.m. EDT.
Location:
Marriott Wardman Park Hotel

Washington, DC
United States

May 9, 2017 8:30 AM EDT
Q1 2017 Spark Therapeutics, Inc. Earnings Conference Call
May 8, 2017 at 12:00 PM EDT to May 10, 2017 at 11:59 PM EDT
Spark Therapeutics, Inc. at Association for Research in Vision and Ophthalmology (ARVO) 2017 Annual Meeting
Description:
  • Kathleen Z. Reape, M.D., head of clinical R&D, will present data on the “Natural History of Individuals with Retinal Degeneration Due to Biallelic Mutations in the RPE65 Gene,” on Monday, May 8, from 8:30 to 10:15 p.m. EDT.
  • Daniel C. Chung, D.O., M.A., clinical ophthalmic lead, will present data on the “Correlation of multi-luminance mobility testing with visual function tests in a Phase 3 trial of voretigene neparvovec for biallelic RPE65-mediated inherited retinal disease,” on Tuesday, May 9, between 11 a.m. - 12:45 p.m. EDT.
  • Stephen R. Russell, M.D., clinical director of the Stephen A. Wynn Institute for Vision Research, University of Iowa, will present “Year 2 results for a Phase 3 trial of voretigene neparvovec in biallelic RPE65-mediated inherited retinal disease,” on Wednesday, May 10, from 8:30 to 10:15 a.m. EDT.
  • Tomas S. Aleman, M.D., associate professor of ophthalmology at the Perelman School of Medicine, University of Pennsylvania, will present “AAV2-hCHM Subretinal Delivery to the Macula in Choroideremia: Preliminary Six Month Safety Results of an Ongoing Phase I/II Gene Therapy Trial” on Wednesday, May 10, from 11:00 a.m. to 12:45 p.m. EDT.
Location:
Baltimore Convention Center

United States

March 15, 2017 4:20 PM EDT
Spark Therapeutics, Inc. at Barclays Global Healthcare Conference
Location:
Loews Miami Beach Hotel

Miami, FL
United States

March 6, 2017 3:20 PM EST
Spark Therapeutics, Inc. at Cowen and Company 37th Annual Health Care Conference
Location:
Boston Marriott Copley Place

Boston, MA
United States

February 23, 2017 12:00 PM EST
Spark Therapeutics, Inc. at RBC Capital Markets Global Healthcare Conference
Location:

New York, NY
United States

February 22, 2017 8:30 AM EST
Q4 2016 Spark Therapeutics, Inc. Earnings Conference Call
February 14, 2017 12:00 PM EST
Spark Therapeutics, Inc. at SunTrust Robinson Humphrey 2017 Orphan Drug Day
Location:

New York, NY
United States

February 14, 2017 12:00 PM EST
Spark Therapeutics, Inc. at BIO CEO & Investor Conference
Description:
Katherine A. High, M.D., president and chief scientific officer, will participate in a Fireside Chat on how Spark Therapeutics, a fully integrated gene therapy company, is creating a value-driven approach in a new field of science and technology on Tuesday, Feb. 14, at 12 p.m. EST
Location:
The Waldorf Astoria

New York, NY
United States

February 1, 2017 2:00 PM CST
Spark Therapeutics, Inc. at European Association for Haemophilia and Allied Disorders (EAHAD)
Description:
  • Katherine A. High, M.D., president and chief scientific officer, will participate in the Pfizer Corporate Symposium on Wednesday, Feb. 1, at 2 p.m. CET
  • Marcus Carr, M.D., head of clinical development, will present previously disclosed data during a presentation on “Preliminary Interim Data from Phase 1/2 Trial: SPK-9001 Adeno-associated Virus Mediated Gene Transfer for Haemophilia B Achieves Sustained Therapeutic Factor IX Activity Levels Without Repetitive Infusions” at the Hot Topics session on Friday, Feb. 3, at 12:30 p.m. CET
Location:
Marriott Rive Gauche Hotel & Conference Centre

Paris
France

January 10, 2017 11:30 AM PST
Spark Therapeutics, Inc. at 35th Annual J.P. Morgan Healthcare Conference
Description:
Click here for Q&A replay.
December 4, 2016 2:00 PM PST
Spark Therapeutics, Inc. at 58th American Society of Hematology (ASH) Annual Meeting
Description:

SPK-9001: Adeno-Associated Virus Mediated Gene Transfer for Hemophilia B Achieves Sustained Mean Factor IX Activity Levels of >30% without Immunosuppression (Abstract # 91358)

Presenter: Lindsey George, M.D., Children's Hospital of Philadelphia
Date: Sunday, Dec. 4, 2016 
Session time: 2-4 p.m. PST
Location: San Diego Convention Center, Hall AB

Location:
San Diego Convention Center, Hall AB

San Diego, CA
United States

November 17, 2016 8:00 AM UTC
Spark Therapeutics, Inc. at Jefferies 2016 London Healthcare Conference
Description:
Stephen Webster, chief financial officer, will present on Thursday, Nov. 17, at 8 a.m. GST
Location:
Waldorf Hilton

London
United Kingdom

November 16, 2016 3:00 PM EST
Spark Therapeutics, Inc. at Stifel 2016 Healthcare Conference
Description:
Stephen Webster, chief financial officer, will present on Wednesday, Nov. 16, at 3 p.m. EST
Location:
Lotte New York Palace Hotel

New York City, NY
United States

November 10, 2016 10:25 AM EST
Spark Therapeutics, Inc. at Retina International Interdisciplinary Open Workshop
Location:
National 4-H Conference Center

Chevy Chase, MD
United States

November 9, 2016 2:05 PM EST
Spark Therapeutics, Inc. at NEI/FDA Endpoints Workshop
Description:
Albert M. Maguire, M.D., professor of ophthalmology at the Perelman School of Medicine of the University of Pennsylvania and principal investigator in the clinical trials of Spark Therapeutics’ investigational therapy voretigene neparvovec, will give a presentation entitled “Endpoints for Gene Therapy Clinical Trials – Low Luminance Mobility Maze”, on Wednesday, Nov. 9, at 2:05 p.m. EST
Location:
Lister Hill Center – NIH Campus

Bethesda, MD
United States

November 8, 2016 1:30 PM MST
Spark Therapeutics, Inc. at Credit Suisse 25th Annual Healthcare Conference
Description:
Jeffrey D. Marrazzo, chief executive officer, will present on Tuesday, Nov. 8, at 1:30 p.m. MST
Location:
The Phoenician

Scottsdale, AZ
United States

November 4, 2016 3:45 PM CDT
Spark Therapeutics, Inc. at Genome Editing for Gene and Cell Therapy, a Herrenhausen Symposium
Description:
Katherine High, M.D., president and chief scientific officer, will participate in a panel discussion entitled “Therapeutics” on Thursday, Nov. 3, at 2:15 p.m. CET, and will give a presentation entitled “AAV-Mediated Gene Therapy for Genetic Disease” on Friday, Nov. 4 at 3:45 p.m. CET
Location:
Herrenhausen Palace Conference Center

Hanover
Germany

November 4, 2016 1:30 PM UTC
Spark Therapeutics, Inc. at Oxford Global 2nd Annual Cell & Gene Therapy Congress
Location:
Radisson Blue

London
United Kingdom

November 3, 2016 8:30 AM EDT
Q3 2016 Spark Therapeutics, Inc. Earnings Conference Call
October 20, 2016 10:30 AM CDT
Spark Therapeutics, Inc. at 2016 European Society of Gene & Cell Therapy (ESGCT)
Description:
Katherine High, M.D., president and chief scientific officer, will participate in the In vivo Gene Therapy session on Thursday, Oct. 20, at 10:30 a.m. (CET)
Location:
Palazzo dei Congressi e degli Affari

Florence
Italy

October 18, 2016 11:00 AM EDT
Spark Therapeutics, Inc. at MIT Review emTech Conference
Description:
Katherine High, M.D., president and chief scientific officer, will speak about “Gene Therapy - A New Era of Medicine” on Tuesday, Oct. 18, at 11 a.m. (EDT)
Location:
MIT Media Lab

Boston, MA
United States

October 17, 2016 11:00 AM EDT
Spark Therapeutics, Inc. at 2016 NORD Rare Diseases & Orphan Products Breakthrough Summit 2016
Description:
Jeffrey D. Marrazzo, chief executive officer, will participate in the "Potential Advances Through Genetic Innovation" panel discussion, on Monday, Oct. 17, at 11 a.m. (EDT)
Location:
Hyatt Regency Crystal City

Arlington, VA
United States

October 14, 2016 12:13 PM CDT
Spark Therapeutics, Inc. at Retina Days Subspecialty Meeting
Description:
Albert M. Maguire, M.D., professor of ophthalmology at the Perelman School of Medicine of the University of Pennsylvania, will talk about “Gene Therapy for Leber Amaurosis Type 2 – Clinical Trials Results,” including data from the pivotal Phase 3 trial of voretigene neparvovec on Friday, Oct. 14, at 12:13 p.m. (CDT).
Location:
McCormick Center in Chicago

United States

October 13, 2016 7:30 AM CDT
Spark Therapeutics, Inc. at 2016 Ophthalmology Innovation Summit
Description:
Jeffrey D. Marrazzo, chief executive officer, will participate in the Gene Therapy Breakfast Break-Out Panel discussion on Thursday, Oct. 13, at 7:30 a.m. (CDT).
Location:
Hyatt Regency Chicago

United States

October 11, 2016 12:00 PM EDT
Spark Therapeutics, Inc. at Jefferies Gene Editing/Gene Therapy Summit
Description:
Company representatives will attend the conference for one-on-one meetings.
Location:
Jefferies Conference Center

New York, NY
United States

October 5, 2016 5:56 PM CDT
Spark Therapeutics, Inc. at 2016 European Association for Vision and Eye Research (EVER) Congress
Description:
Bart Leroy, M.D., director of the Ophthalmic Genetics and Retinal Degenerations clinics in the Division of Ophthalmology and Center for Cellular and Molecular Therapeutics at The Children's Hospital of Philadelphia, will speak about “Current gene therapy trials for inherited retinal disorders” on Wednesday, Oct. 5, at 5:56 p.m. (CET). Dr. Leroy is an investigator in the clinical development program for voretigene neparvovec, Spark Therapeutics’ lead investigational gene therapy for RPE-65 mediated inherited retinal disease.
Location:
Acropolis Convention Center

Nice
France

October 3, 2016 12:50 PM EDT
Spark Therapeutics, Inc. at XII International Conference of the Argentinian Society of Retina and Vitreous
Description:
Paolo Falabella, M.D., Medical Affairs Ophthalmic Lead, will talk about “Investigational ocular gene therapy for RPE65-mediated retinal dystrophy” on Monday, Oct. 3, at 12:50 p.m. (EDT)
Location:
Hotel Arakur

Ushuaia
Argentina

September 28, 2016 3:40 PM EDT
Spark Therapeutics, Inc. at 2016 Leerink Partners Rare Disease Roundtable Series
Description:
Stephen Webster, chief financial officer, will participate in the Rare Disease and Immuno-Oncology roundtable discussion on Wednesday, Sept. 28, at 3:40 p.m. (EDT)
Location:
Lotte NY Palace

New York, NY
United States

September 14, 2016 12:00 PM EDT
Spark Therapeutics, Inc. at Bank of America / Merrill Lynch (BAML) Global HC Conference 2016
Location:
BOA/ML Financial Centre

London
United Kingdom

September 9, 2016 12:00 PM EDT
Spark Therapeutics, Inc. at Goldman Sachs 6th Annual Biotech Symposium
Location:
Goldman Sachs’ Office

London
United Kingdom

September 9, 2016 5:24 PM CEST
Spark Therapeutics, Inc. at 16th Congress of the European Retina, Macula and Vitreous Society (EURETINA)
Location:
Bella Center

Copenhagen
Denmark

September 7, 2016 4:55 PM EDT
Spark Therapeutics, Inc. at Baird 2016 Global Healthcare Conference
September 7, 2016 1:00 PM EDT
Spark Therapeutics, Inc. at Citibank’s 11th Annual Biotech Conference
August 10, 2016 8:30 AM EDT
Q2 2016 Spark Therapeutics, Inc. Earnings Conference Call
July 25, 2016 4:00 PM EDT
World Federation of Hemophilia (WFH) 2016 World Congress
Description:

Dr. Lindsey George, a hematologist at the Children's Hospital of Philadelphia and the lead clinical investigator in the Phase 1/2 clinical trial of SPK-9001 for the treatment of hemophilia B, will present a moderated poster presentation on Monday July 25, 2016 at 4:00 pm (ET)

Dr. George also will present at a late-breaking abstract session on gene therapy on Wednesday July 27, 2016 at 2:15 pm (ET).

July 13, 2016 10:45 AM EDT
Cantor Fitzgerald’s 2nd Annual Healthcare Conference
Description:
Stephen Webster, Spark’s chief financial officer, will present on Wednesday July 13, 2016 at 10:45 am (ET) and also will participate in a gene therapy panel at 12:15 pm (ET)
June 23, 2016 12:00 PM EDT
Spark Therapeutics Inc at J.P. Morgan 4th Annual European Healthcare Conference
June 22, 2016 12:00 PM EDT
Spark Therapeutics, Inc. at Roth Capital Partners 3rd Annual ROTH Healthcare Day
June 13, 2016 8:30 AM EDT
Spark Therapeutics, Inc. Call to Discuss Hemophilia Franchise
June 11, 2016 12:00 PM EDT
Spark Therapeutics, Inc. at European Hematology Association
Description:

Dr. Katherine High will present at the European Hematology Association press briefing on Saturday June 11, 2016, at 8:30 am Central European Time (CET), and Dr. Spencer Sullivan, clinical investigator on the trial, will present the abstract data on June 11 at 5:30 pm (CET), in Copenhagen, Denmark.

June 10, 2016 2:00 PM EDT
Spark Therapeutics, Inc. at Jefferies 2016 Healthcare Conference
June 7, 2016 4:00 PM EDT
Spark Therapeutics, Inc. at Goldman Sachs 37th Annual Global Healthcare Conference
June 7, 2016 at 12:00 PM EDT to June 9, 2016 at 11:59 PM EDT
Spark Therapeutics, Inc. at 2016 BIO International Convention
Description:
  • Dr. Daniel Takefman, head of regulatory affairs; Genetic Medicines Come of Age: The Challenges and Opportunities; Tuesday June 7, 2016, at 2:15 pm (PT)
  • Jeffrey D. Marrazzo, chief executive officer; Curative Therapies: Aligning Policy with Science to Ensure Patient Access; Wednesday June 8, 2016, at 10:45 am (PT)
  • Dr. Katherine High, president and chief scientific officer; Gene Therapy or CRISPR: Which One Will Change the Future of Medical Care?; Thursday June 9, 2016, at 9:00 am (PT)
May 23, 2016 12:00 PM EDT
Spark Therapeutics, Inc. at UBS 2016 Global Healthcare Conference
May 17, 2016 12:00 PM EDT
Spark Therapeutics, Inc. at Piper Jaffray GenomeRX Symposium
May 4, 2016 8:30 AM EDT
Q1 2016 Spark Therapeutics, Inc. Earnings Conference Call
May 4, 2016 8:00 AM EDT
Spark Therapeutics, Inc. at Deutsche Bank 41st Annual Healthcare Conference
March 9, 2016 8:30 AM EST
Q4 2015 Spark Therapeutics, Inc. Earnings Conference Call
January 11, 2016 4:30 PM PST
Spark Therapeutics, Inc. at J.P. Morgan 34th Annual Healthcare Conference
December 6, 2015 12:00 PM EST
Spark Therapeutics, Inc. at 57th American Society of Hematology (ASH) Annual Meeting & Exposition
December 3, 2015 12:00 PM EST
Spark Therapeutics, Inc. at 2015 Genetic Rx Boston Conference
December 1, 2015 12:00 PM EST
Spark Therapeutics, Inc. at 27th Annual Piper Jaffray Healthcare Conference
November 18, 2015 8:45 AM EST
Spark Therapeutics, Inc. at Stifel 2015 Healthcare Conference
November 12, 2015 4:20 PM PST
Spark Therapeutics, Inc. at Ophthalmology Innovation Summit (OIS) at American Academy of Ophthalmology (AAO) 2015
November 11, 2015 1:30 PM MST
Spark Therapeutics, Inc. at 24th Annual Credit Suisse Healthcare Conference
November 4, 2015 8:30 AM EST
Q3 2015 Spark Therapeutics, Inc. Earnings Conference Call
October 27, 2015 12:00 PM EDT
Spark Therapeutics, Inc. at ROTH Capital Partners Gene Therapy Corporate Access Day
October 5, 2015 8:30 AM EDT
Spark Therapeutics, Inc. Conference Call
September 10, 2015 8:30 AM EDT
Spark Therapeutics, Inc. Conference Call
August 5, 2015 8:30 AM EDT
Q2 2015 Spark Therapeutics, Inc. Earnings Conference Call
June 25, 2015 12:00 PM EDT
Spark Therapeutics, Inc. at J.P. Morgan Cazenove European Healthcare Conference
June 24, 2015 12:00 PM EDT
Spark Therapeutics, Inc. at 2nd Annual ROTH Healthcare Day
May 6, 2015 8:30 AM EDT
Q1 2015 Spark Therapeutics, Inc. Earnings Conference Call
March 4, 2015 10:40 AM EST
Spark Therapeutics, Inc. at 35th Annual Cowen and Company Health Care Conference
Supporting 
Materials: 

Supporting Materials